OnKure Therapeutics (OKUR) Assets Average (2021 - 2026)

OnKure Therapeutics (OKUR) has reported Assets Average for 6 consecutive years, with $189.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Assets Average rose 103.3% year-over-year to $189.0 million; the trailing twelve-month figure through Jun 2026 stood at $189.0 million (up 103.3% YoY), and the FY2025 full-year result was $88.5 million, up 17.51% from the prior year.
• Assets Average advanced to $189.0 million in Q2 2026 per OKUR's latest filing, from $130.4 million in the prior quarter.
• Across five years, Assets Average topped out at $189.0 million in Q2 2026 and bottomed at $60.2 million in Q1 2024.
• Historically, Assets Average has averaged $109.1 million across 5 years, with a median of $105.5 million in 2023.
• The sharpest annual moves came in 2024 and 2026: Assets Average slumped 43.84% in 2024, then jumped 103.3% in 2026.
• Over 5 years, Assets Average stood at $115.3 million in 2022, then slipped by 27.99% to $83.1 million in 2023, then advanced by 15.91% to $96.3 million in 2024, then fell by 29.91% to $67.5 million in 2025, then jumped by 180.13% to $189.0 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $189.0 million, $130.4 million, and $67.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.